Abstract
The ideal gene therapy for metabolical liver disorders would target hepatocytes before the onset of disease and be durable, non-toxic and non-immunogenic. Early gestational gene transfer can achieve such goals. Here, we demonstrate that prenatal gene transfer of human Atp7b reduces liver pathology and improves biochemical markers in Atp7b−/− mice, a murine model of Wilson's disease (WD). Following prenatal injection of lentivirus vector containing the human Atp7b gene under the transcriptional control of a liver-specific promoter, the full-length ATP7B was detectable in mouse livers for the entire duration of experiments (20 weeks after birth). In contrast to a marked pathology in non-injected animals, livers from age-matched treated mice consistently demonstrated normal gross and histological morphology. Hepatic copper content was decreased in the majority of treated mice, although remaining copper levels varied. Improvement of hepatic copper metabolism was further apparent from the presence of copper-bound ceruloplasmin in the sera and normalization of the mRNA levels for HMG CoA-reductase. With this approach, the complete loss of copper transport function can be ameliorated, as evident from phenotypical improvement in treated Atp7b−/− mice. This study provides proof of principle for in utero gene therapy in WD and other liver-based enzyme deficiencies.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- WD:
-
Wilson's disease
- ATP7B:
-
adenosine triphosphate 7B
- LSP:
-
liver-specific promoter
- GFP:
-
green fluorescent protein
- MND:
-
modified myeloid proliferative sarcoma virus promoter
- HMG CoA reductase:
-
3-hydroxy-3-methyl-glutaryl-CoA reductase
References
Ala A, Schilsky ML . Wilson disease: pathophysiology, diagnosis, treatment, and screening. Clin Liver Dis 2004; 8: 787–805.
Riordan SM, Williams R . The Wilson's disease gene and phenotypic diversity. J Hepatol 2001; 34: 165–171.
Merle U, Schaefer M, Ferenci P, Stremmel W . Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study. Gut 2007; 56: 115–120.
Merle U, Stremmel W, Encke J . Perspectives for gene therapy of Wilson disease. Curr Gene Ther 2007; 7: 217–220.
Malhi H, Irani AN, Volenberg I, Schilsky ML, Gupta S . Early cell transplantation in LEC rats modeling Wilson's disease eliminates hepatic copper with reversal of liver disease. Gastroenterol 2002; 122: 438–447.
Terada K, Nakako T, Yang XL, Iida M, Aiba N, Minamiya Y et al. Restoration of holoceruloplasmin synthesis in LEC rat after infusion of recombinant adenovirus bearing WND cDNA. J Biol Chem 1998; 273: 1815–1820.
Ha-Hao D, Merle U, Hofmann C, Wesch H, Doll J, Auburger G et al. Chances and shortcomings of adenovirus-mediated ATP7B gene transfer in Wilson disease: proof of principle demonstrated in a pilot study with LEC rats. Gastroenterol 2002; 40: 209–216.
Merle U, Encke J, Tuma S, Volkmann M, Naldini L, Stremmel W . Lentiviral gene transfer ameliorates disease progression in Long-Evans cinnamon rats: an animal model for Wilson disease. Scand J Gastroenterol 2006; 41: 974–982.
Meng Y, Miyoshi I, Hirabayashi M, Su M, Mototani Y, Okamura T et al. Restoration of copper metabolism and rescue of hepatic abnormalities in LEC rats, an animal model of Wilson disease, by expression of human ATP7B gene. Biochim Biophys Acta 2004; 1690: 208–219.
Roybal JL, Santore MT, Flake AW . Stem cell and genetic therapies for the fetus. Semin Fetal Neonatal Med 2010; 15: 46–51.
Loudianos G, Figus AL, Loi A, Angius A, Dessì V, Deiana M et al. Improvement of prenatal diagnosis of Wilson disease using microsatellite markers. Prenat Diagn 1994; 14: 999–1002.
Endo M, Henriques-Coelho T, Zoltick PW, Stitelman DH, Peranteau WH, Radu A et al. The developmental stage determines the distribution and duration of gene expression after early intra-amniotic gene transfer using lentiviral vectors. Gene Therapy 2010; 17: 61–71.
Roybal JL, Endo M, Radu A, Zoltick PW, Flake AW . Early gestational gene transfer of IL-10 by systemic administration of lentiviral vector can prevent arthritis in a murine model. Gene Therapy 2011; 18: 719–726.
Stitelman DH, Endo M, Bora A, Muvarak N, Zoltick PW, Flake AW et al. Robust in vivo transduction of nervous system and neural stem cells by early gestational intra amniotic gene transfer using lentiviral vector. Mol Ther 2010; 18: 1615–1623.
Niiya M, Endo M, Shang D, Zoltick PW, Muvarak NE, Cao W et al. Correction of ADAMTS13 deficiency by in utero gene transfer of lentiviral vector encoding ADAMTS13 genes. Mol Ther 2009; 17: 34–41.
Endo M, Zoltick PW, Peranteau WH, Radu A, Muvarak N, Ito M et al. Efficient in vivo targeting of epidermal stem cells by early gestational intraamniotic injection of lentiviral vector driven by the keratin 5 promoter. Mol Ther 2008; 16: 131–137.
Endo M, Zoltick PW, Chung DC, Bennett J, Radu A, Muvarak N et al. Gene transfer to ocular stem cells by early gestational intraamniotic injection of lentiviral vector. Mol Ther 2007; 15: 579–587.
Buiakova OI, Xu J, Lutsenko S, Zeitlin S, Das K, Das S et al. Null mutation of the murine ATP7B (Wilson disease) gene results in intracellular copper accumulation and late-onset hepatic nodular transformation. Hum Mol Genet 1999; 8: 1665–1671.
Huster D, Finegold MJ, Morgan CT, Burkhead JL, Nixon R, Vanderwerf SM et al. Consequences of copper accumulation in the livers of the Atp7b−/− (Wilson disease gene) knockout mice. Am J Pathol 2006; 168: 423–434.
Lutsenko S . Atp7b−/− mice as a model for studies of Wilson's disease. Biochem Soc Trans 2008; 36: 1233–1238.
Huster D, Lutsenko S . Wilson disease: not just a copper disorder. Analysis of a Wilson disease model demonstrates the link between copper and lipid metabolism. Mol Biosyst 2007; 3: 816–824.
Huster D, Purnat TD, Burkhead JL, Ralle M, Fiehn O, Stuckert F et al. High copper selectively alters lipid metabolism and cell cycle machinery in the mouse model of Wilson disease. J Biol Chem 2007; 282: 8343–8355.
Kaplan JH, Lutsenko S . Copper transport in mammalian cells: special care for a metal with special needs. J Biol Chem 2009; 284: 25461–25465.
Mercer JF, Barnes N, Stevenson J, Strausak D, Llanos RM . Copper-induced trafficking of the cU-ATPases: a key mechanism for copper homeostasis. Biometals 2003; 16: 175–184.
Bunce GE . Hypercholesterolemia of copper deficiency is linked to glutathione metabolism and regulation of hepatic HMG-CoA reductase. Nutr Rev 1993; 51: 305–307.
Ralle M, Huster D, Vogt S, Schirrmeister W, Burkhead JL, Capps TR et al. Wilson's disease at a single cell level: intracellular copper trafficking activates compartment-specific responses in hepatocytes. J Biol Chem 2010; 285: 30875–30883.
Sissman NJ . Developmental landmarks in cardiac morphogenesis: comparative chronology. Am J Cardiol 1970; 25: 141–148.
Miyoshi H, Blömer U, Takahashi M, Gage FH, Verma IM . Development of a self-inactivating lentivirus vector. J Virol 1998; 72: 8150–8157.
Robbins PB, Yu XJ, Skelton DM, Pepper KA, Wasserman RM, Zhu L et al. Increased probability of expression from modified retroviral vectors in embryonal stem cells and embryonal carcinoma cells. J Virol 1997; 71: 9466–9474.
Higuchi R, Krummel B, Saiki RK . A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions. Nuc Acid Res 1988; 16: 7352–7367.
Heckman KL, Pease LR . Gene splicing and mutagenesis by PCR-driven overlap extension. Nat Protoc 2007; 2: 924–932.
Qin XF, An DS, Chen IS, Baltimore D . Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of interfering RNA against CCR5. Proc Natl Acad Sci 2003; 100: 183–188.
Margaritis P, Arruda VR, Aljamali M, Camire RM, Schlachterman A, High KA . Novel therapeutic approach for hemophilia using gene delivery of an engineered secreted activated Factor VII. J Clin Invest 2004; 113: 1025–1031.
Sena-Esteves M, Tebbets JC, Steffens S, Crombleholme T, Flake AW . Optimized large-scale production of high titer lentivirus vector pseudotypes. J Virol Methods 2004; 122: 131–139.
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ . Protein measurement with the Folin-Phenol reagents. J Biol Chem 1951; 193: 265–275.
Acknowledgements
The authors thank Dr Jeffrey M Bergelson (Children's Hospital of Philadelphia) for the enterocyte line Caco-2, Dr David Baltimore (California Institute of Technology) for the HIV-1-based transfer vector, a modified FG12 plasmid, Dr Katherine A High (Children's Hospital of Philadelphia) for the liver-specific promoter, Archana Bora (Children's Hospital of Philadelphia) for help with qRT-PCR, and Keith Alcorn (Children's Hospital of Philadelphia) for help with animal husbandry, and Dr Ann Hubbard (Johns Hopkins University) for helpful discussions. JLR was supported by grant 5T32HD46402 from the National Institutes of Health (AWF); SL and LG were supported by grant P01 GM067166 from the National Institutes of Health to SL. Additional support was provided by funds from the Ruth and Tristram C Colket, Jr Chair of Pediatric Surgery (AWF).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on Gene Therapy website
Rights and permissions
About this article
Cite this article
Roybal, J., Endo, M., Radu, A. et al. Early gestational gene transfer with targeted ATP7B expression in the liver improves phenotype in a murine model of Wilson's disease. Gene Ther 19, 1085–1094 (2012). https://doi.org/10.1038/gt.2011.186
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/gt.2011.186
Keywords
This article is cited by
-
In Utero Gene Therapy and Genome Editing
Current Stem Cell Reports (2018)
-
Bioavailable Trace Metals in Neurological Diseases
Current Treatment Options in Neurology (2016)
-
Developmental stage determines efficiency of gene transfer to muscle satellite cells by in utero delivery of adeno-associated virus vector serotype 2/9
Molecular Therapy - Methods & Clinical Development (2014)